REG-Syncona Limited: Directorate Change <Origin Href="QuoteRef">SYNCS.L</Origin>

SynconaAnnouncement

08/09/2017 16:40

8 September 2017
 

Syncona Limited
Legal Entity Identifier – 213800X8MBI5VQITLW60

Directorate Change

The Company announces the resignation of Peter Hames as a non-executive
director of the Company, effective as of the completion of the Company’s
Annual General Meeting today, 8 September 2017.  Mr. Hames has been a Board
member since the Company listed in 2012, and the Company wishes to thank him
for his invaluable contribution.
 

 ENDS 

Enquiries

Northern Trust International Fund Administration Services (Guernsey) Limited
Company Secretary
Tel:       01481 745001

Copies of this announcement and other corporate information can be found on
the company website at:www.synconaltd.com 

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and
building global leaders in life science. Our vision is to deliver
transformational treatments to patients in truly innovative areas of
healthcare while generating superior returns for shareholders. Our current
investment portfolio consists of seven high quality companies in life science
and a leading range of fund investments.

We seek to partner with the best, brightest and most ambitious minds in
science to build globally competitive businesses. We are established leaders
in gene therapy, cell therapy and advanced diagnostics, and focus on
delivering dramatic efficacy for patients in areas of high unmet need.

Our market leading funds portfolio seeks to generate superior returns by
investing in long only and alternative investment funds. This represents a
productively deployed evergreen funding base which enables us to take a long
term approach to investing in life sciences as we target the best new
opportunities and support our existing portfolio companies to grow and
succeed.

Syncona is aligned with two of the premium charitable funders in UK science,
the Wellcome Trust, original founder of Syncona, and Cancer Research UK, both
of which are significant shareholders in our business.  We make a donation of
0.3% of Net Asset Value to a range of charities each year.



Copyright (c) 2017 PR Newswire Association,LLC. All Rights Reserved